A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: Baricitinib;   Drug: Topical corticosteroid;   Drug: Placebo Sponsors:   Eli Lilly and Company;   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials